Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

0.6425
-0.0277-4.13%
Volume:451.12K
Turnover:295.56K
Market Cap:31.19M
PE:-0.40
High:0.6776
Open:0.6600
Low:0.6302
Close:0.6702
52wk High:2.38
52wk Low:0.5301
Shares:48.54M
Float Shares:35.00M
Volume Ratio:2.74
T/O Rate:1.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.05
PE(LYR):-0.39

Loading ...

Former 10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 05, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025

MPM BioVentures 2014 L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 26, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 26, 2025

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Nov 26, 2025

Werewolf Therapeutics Is Maintained at Buy by B of A Securities

Dow Jones
·
Nov 19, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18, 2025

10% Owner Ansbert Gadicke Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18, 2025

Director Luke Evnin Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 13, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 13, 2025

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Nov 13, 2025

Werewolf Therapeutics Unveils Tumor-Selective INDUKINE Data at SITC 2025

Reuters
·
Nov 07, 2025

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 07, 2025

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 07, 2025

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 07, 2025

Wedbush Halves Price Target on Werewolf Therapeutics to $3 From $6, Keeps Outperform Rating

MT Newswires Live
·
Nov 05, 2025

Werewolf Therapeutics reports Q3 EPS (36c), consensus (38c)

TIPRANKS
·
Nov 04, 2025